Sanofi (0A2V) Financial Statements
Sanofi Financial Overview
Sanofi's market cap is currently $107.18B. The company's EPS TTM is $0.48; its P/E ratio is 24.39; and it has a dividend yield of 5.71%. Sanofi is estimated to report earnings on January 28, 2027, and the estimated EPS forecast is $1.02. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 46.72B | $ 44.29B | $ 41.62B | $ 40.56B | $ 39.17B |
| Gross Profit | $ 33.67B | $ 31.08B | $ 28.99B | $ 28.68B | $ 26.92B |
| Operating Income | $ 9.60B | $ 7.25B | $ 6.96B | $ 10.16B | $ 8.13B |
| EBITDA | $ 12.48B | $ 11.03B | $ 11.39B | $ 13.51B | $ 11.54B |
| Net Income | $ 7.81B | $ 5.56B | $ 5.40B | $ 8.37B | $ 6.22B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 8.47B | $ 7.93B | $ 8.71B | $ 12.74B | $ 10.10B |
| Total Assets | $ 126.81B | $ 132.80B | $ 126.46B | $ 126.72B | $ 120.24B |
| Total Debt | $ 20.33B | $ 17.91B | $ 18.70B | $ 21.21B | $ 22.41B |
| Net Debt | $ 12.67B | $ 10.46B | $ 9.99B | $ 8.48B | $ 12.32B |
| Total Liabilities | $ 55.09B | $ 54.94B | $ 52.11B | $ 51.57B | $ 51.21B |
| Stockholders' Equity | $ 71.38B | $ 77.51B | $ 74.04B | $ 74.78B | $ 68.68B |
| Cash Flow | |||||
| Free Cash Flow | $ 10.14B | $ 5.89B | $ 7.35B | $ 8.42B | $ 8.48B |
| Operating Cash Flow | $ 12.13B | $ 9.08B | $ 10.26B | $ 10.53B | $ 10.52B |
| Investing Cash Flow | $ -2.76B | $ -4.41B | $ -6.20B | $ -2.08B | $ -7.30B |
| Financing Cash Flow | $ -9.26B | $ -5.76B | $ -8.05B | $ -5.82B | $ -7.06B |
Currency in EUR